November 10, 2025
Tag: Head and Neck Cancer Clinical Program
October 13, 2025
Precision Oncology: Unmet Needs in R/M HNSCC: The Rationale for Study 1100
September 24, 2025
STAT News: Anthony Letai of Dana-Farber is front-runner to lead National Cancer Institute
September 24, 2025
Precision Medicine Online: Iovance’s Amtagvi Shows Modest Monotherapy Activity in Head and Neck Cancer
September 15, 2025
Targeted Oncology: Autologous TIL Cell Therapy: A Potential Next Line of Treatment for HNSCC
August 26, 2025
Immune cell therapy for advanced head and neck cancer helps stabilize disease
Robert Ferris, MD, PhD, and colleagues report that a single administration of autologous tumor-infiltrating lymphocyte cell therapy helped stabilize metastatic head and neck squamous cell carcinoma in some patients.
August 22, 2025
Targeted Oncology: Sustaining Cancer Research and Oncology: A Call to Congress
August 15, 2025
UNC Lineberger launches groundbreaking trial for rare, aggressive thyroid cancer
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.
July 29, 2025
Faith, advocacy and determination shaped patient’s journey to survivorship
Kwame Kwofie, a citizen of Ghana, found himself in uncharted territory when he faced a head and neck cancer diagnosis thousands of miles away from home.
July 29, 2025